Immunodominant epitope and properties of pyroglutamate-modified Aβ-specific antibodies produced in rabbits

Journal of Neuroimmunology

Volumn 213, Issue 1-2, 2009, Pages 39-46

  Acero, G ^a   Manoutcharian, K ^a   Vasilevko, V ^b   Munguia, M E ^a   Govezensky, T ^a   Coronas, G ^a   Luz Madrigal, A ^a   Cribbs, D H ^b   Gevorkian, G ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease immunotherapy; Immunodominant epitope; N truncated amyloid beta (A ) peptide

Indexed keywords

AMYLOID BETA PROTEIN; EPITOPE; IMMUNOGLOBULIN G; PHOSPHATIDYLSERINE; POLYCLONAL ANTIBODY; PYROGLUTAMIC ACID;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE MODEL; DOWN SYNDROME; DRUG TARGETING; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE DAMAGE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN MODIFICATION; RABBIT; SENILE PLAQUE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ALZHEIMER VACCINES; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; CELL LINE, TUMOR; CELL MEMBRANE; HUMANS; IMMUNODOMINANT EPITOPES; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; PEPTIDES; PHOSPHATIDYLSERINES; PROTEIN STRUCTURE, TERTIARY; PYRROLIDONECARBOXYLIC ACID; RABBITS;

EID: 68049116924     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.06.003     Document Type: Article

References (53)

1. Bard F., Cannon C., Barbour R., Burke R.-L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch K., Seubert P., Schenk D., and Yednock T. Peripherally administered antibodies against amyloid-β peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease. Nat. Med. 6 (2000) 916-919
2. Bayer T.A., Breyahn H., Duan K., Rettig J., and Wirths O. Intraneuronal β-amyloid is a major risk factor - novel evidence from the APP/PS1KI mouse model. Neurodegener. Dis. 5 (2008) 140-142
3. Berg M.M., Krafft G.A., and klein W.L. Rapid impact of β-amyloid on paxillin in a neural cell line. J. Neurosci. Res. 50 (1997) 979-989
4. Brody D.L., and Holtzman D.M. Active and passive immunotherapy for neurodegenerative disorders. Annu. Rev. Neurosci. 31 (2008) 175-193
5. Casas C., Sergeant N., Itier J.-M., Blanchard V., Wirths O., van der Kolk N., Vingtdeux V., van de Steeg E., Ret G., Canton T., Drobecq H., Clark A., Bonici B., Delacourte A., Benavides J., Schmitz C., Tremp G., Bayer T.A., Benoit P., and Pradier L. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Aβ42 accumulation in a novel Alzheimer transgenic model. Am. J. Pathol. 165 (2004) 1289-1300
6. Chang L., Bakhis L., Wang Z., Venton D.L., and Klein W.L. Femtomole immunodetection of synthetic and endogenous amyloid-β oligomers and its application to Alzheimer's disease drug candidate screening. J. Mol. Neurosci. 20 (2003) 305-313
7. Daly R.J. The Grb7 family of signaling proteins. Cell. Signal. 10 (1998) 613-618
8. Frasca G., Carbonaro V., Merlo S., Copani A., and Sortino M.A. Integrins mediate β-amyloid-induced cell-cycle activation and neuronal death. J. Neurosci. Res. 86 (2008) 350-355
9. Gevorkian G., Manoutcharian K., Govezensky T., Cano A., Dominguez V., Santamaria H., and Larralde C. Identification of mimotopes of platelet autoantigens associated with autoimmune thrombocytopenic purpura. J. Autoimmun. 15 (2000) 33-40
10. Gevorkian G., Petrushina I., Manoutcharian K., Ghochikyan A., Acero G., Vasilevko V., Cribbs D.H., and Agadjanyan M.G. Mimotopes of conformational epitopes in fibrillar β-amyloid. J. Neuroimmunol. 156 (2004) 10-20
11. Grace E.A., and Busciglio J. Aberrant activation of focal adhesion proteins mediates fibrillar amyloid β-induced neuronal dystrophy. J. Neurosci. 23 (2002) 493-502
12. Guntert A., Dobeli H., and Bohrmann B. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Neuroscience 143 (2006) 461-475
13. Haass C., and Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell. Biol. 8 (2007) 101-112
14. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
15. Harigaya Y., Saido T.C., Eckman C.B., Prada C.-M., Shoji M., and Younkin S.G. Amyloid β protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain. Biochem. Biophys. Res. Commun. 276 (2000) 422-427
16. He W., and Barrow C.J. The Aβ 3-Pyroglutamyl and 11-Pyroglutamyl Peptides Found in Senile Plaque Have Greater β-sheet Forming and Aggregation Propensities In Vitro than Full-length Aβ (1999)
17. Head E., Pop V., Vasilevko V., Hill M., Saing T., Sarsoza F., Nistor M., Christie L.A., Milton S., Glabe C., Barrett E., and Cribbs D. A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta. J. Neurosci. 28 (2008) 3555-3566
18. Huse J.T., Liu K., Pijak D.S., Carlin D., Lee V.M.-Y., and Doms R.W. β-Secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain. J. Biol. Chem. 277 (2002) 16278-16284
19. Kalback W., Watson M.D., Kokjohn T.A., Kuo Y.M., Weiss N., Luehrs D.C., Lopez J., Brune D., Sisodia S.S., Staufenbiel M., Emmerling M., and Roher A.E. APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques. Biochemistry 41 (2002) 922-928
20. Klein W.L. Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 41 (2002) 345-352
21. Kumar-Singh S., De Jonghe C., Cruts M., Kleinert R., Wang R., Mercken M., De Strooper B., Vanderstichele H., Lofgren A., Vanderhoeven I., Backhovens H., Vanmechelen E., Kroisel P.M., and Van Broeckhoven C. Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta842) in Alzheimer's disease. Hum. Mol. Genet. 9 (2000) 2589-2598
22. Kuo Y.M., Emmerling M.R., Woods A.S., Cotter R.J., and Roher A.E. Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. Biochem. Biophys. Res. Commun. 237 (1997) 188-191
23. Lambert M.P., Stevens G., Sabo S., Barber K., Wang G., Wade W., Krafft G., Snyder S., Holzman T.F., and Klein W.L. Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells. J. Neurosci. Res. 39 (1994) 377-385
24. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., liosatos M., Morgand T.E., Rosovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., and Klein W.L. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl.Acad. Sci. USA 95 (1998) 6448-6453
25. Lemere C.A., Beierschmitt A., Iglesias M., Spooner E.T., Bloom J.K., Leverone J.F., Zheng J.B., Seabrook T.J., Louard D., Li D., Selkoe D.J., Palmour R.M., and Ervin F.R. Alzheimer's disease Aβ vaccine reduces central nervous system Aβ levels in a non-human primate, the Caribbean vervet. Am. J. Pathol. 165 (2004) 283-297
26. Liu K., Solano I., Mann D., Lemere C., Mercken M., Trojanowski J.Q., and Lee V.M.-Y. Characterization of Ab11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Aβ species in the pathogenesis of Alzheimer's disease. Acta Neuropathol. 112 (2006) 163-174
27. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., and Beyreyther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U S A 82 (1985) 4245-4249
28. Miravalle L., Calero M., Takao M., Roher A.E., Ghetti B., and Vidal R. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry 44 (2005) 10810-10821
29. Mori H., Takio K., Ogawara M., and Selkoe D.J. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. J. Biol. Chem. 267 (1992) 17082-17086
30. Naslund J., Schierhorn A., Hellman U., Lannfelt L., Roses A.D., Tjernberg L.O., Silberring J., Gandy S.E., Winblad B., Greengard P., Nordstedt C., and Terenius L. Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging. Proc. Natl. Acad. Sci. USA 91 (1994) 8378-8382
31. Piccini A., Russo C., Gliozzi A., Relini A., Vitali A., Borghi R., Giliberto L., Armirotti A., D'Arrigo B.A., Cattaneo A., Canale C., Torrassa S., Saido T.C., Markesbery W., Gambetti P., and Tabaton M. β-amyloid is different in normal aging and in Alzheimer disease. J. Biol. Chem. 280 (2005) 34186-34192
32. Pike C.J., Overman M.J., and Cotman C.W. Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. J. Biol. Chem. 270 (1995) 23895-23898
33. Russo C., Salis S., Dolcini V., Venezia V., Song X.-H., Teller J.K., and Schettini G. Identification of amino-terminally and phosphotyrosine-modified carboxy-terminal fragments of amyloid precursor protein in Alzheimer's disease and Down syndrome brain. Neurobiol. Dis. 8 (2001) 173-180
34. Russo C., Violani E., Salis S., Venezia V., Dolcini V., Damonte G., Benatti U., D'Arrigo C., Patrone E., Carlo P., and Schettini G. Pyroglutamate-modified amyloid-peptides - a N3(pE) - strongly affect cultured neuron and astrocyte survival. J. Neurochem. 82 (2002) 1480-1489
35. Saido T.C., Iwatsubo T., Mann D.M.A., Shimada H., Ihara Y., and Kawashima S. Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques. Neuron 14 (1995) 457-466
36. Saido T.C., Yamao-Harigaya W., Iwatsubo T., and Kawashima S. Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain. Neurosci. Lett. 215 (1996) 173-176
37. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., and Seubert P. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
38. Schilling S., Lauber T., Schaupp M., Manhart S., Scheel E., Bohm G., and Demuth H.-U. On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Biochemistry 45 (2006) 12393-12399
39. Schilling S., Zeitschel U., Hoffmann T., Heiser U., Francke M., Kehlen A., Holzer M., Hutter-Paier B., Prokesch M., Windisch M., Jagla W., Sch lenzig D., landler C., Rudolph T., Reuter G., Cynis H., Montag D., Demuth H.U., and Rossner S. Glutaminyl cyclase inhibition attenuates pyroglutamate Ab and Alzheimer's disease-like pathology. Nat. Med. 14 (2008) 1106-1111
40. Sergeant N., Bombois S., Ghestem A., Drobecq H., Kostanjevecki V., Missiaen C., Wattez A., David J.-P., Vanmechelen E., Sergheraert C., and Delacourte A. Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. J. Neurochem. 85 (2003) 1581-1591
41. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schiossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Lieberburg I., and Schenk D. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359 (1992) 325-327
42. Shen T.L., and Guan J.L. Grb7 intracellular signaling and its role in cell regulation. Front. Biosci. 9 (2004) 192-200
43. Sherer T.B., Trimmer P.A., Borland K., Parks J.K., Bennett Jr. J.P., and Tuttle J.B. Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells. Brain Res. 891 (2001) 94-105
44. Solórzano-Vargas R.S., Vasilevko V., Acero G., Ugen K.E., Martinez R., Govezensky T., Vazquez-Ramirez R., Kubli-Garfias C., Cribbs D.H., Manoutcharian K., and Gevorkian G. Epitope mapping and neuroprotective properties of a human single Chain Fv antibody that binds an internal epitope of amyloid-beta 1-42. Mol. Immunol. 45 (2008) 881-886
45. Tekirian T.L., T.C., Markesbery W.R., Russel M.J., Wekstein D.R., Patel E., and Geddes J.W. N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits. J. Neuropathol. Exp. Neurol. 57 (1998) 76-94
46. Town T., tan J., Sansone N., Obregon D., Klein T., and Mullan M. Characterization of murine immunoglobulin G antibodies against human amyloid-beta 1-42. Neurosci. Lett. 307 (2001) 101-104
47. Vanderstichele H., De Meyer G., Andreasen N., Kostanjevecki V., Wallin A., Olsson A., Blennow K., and Vanmechelen E. Amino-truncated β-amyloid 42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment. Clin. Chem. 51 (2005) 1650-1660
48. Vermes I., Haanen C., Steffens-Nakken H., and Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J. Immunol. Methods 184 (1995) 39-51
49. Walsh D.M., and Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 (2004) 181-193
50. Williamson R., Scales T., Clark B.R., Gibb G., Reynolds C.H., Kellie S., Bird I.N., Varndell I.M., Sheppard P.W., Everall I., and Anderton B.H. Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-β peptide exposure: involvement of src family protein kinase. J. Neurosci. 22 (2002) 10-20
51. Wirths O., Weis J., Kayed R., Saido T.C., and Bayer T.A. Age-dependent axonal degeneration in an Alzheimer mouse model. Neurobiol. Aging 28 (2007) 1689-1699
52. Youssef I., Florent-Bechard S., malaplate-Armand C., Koziel V., Bihain B., Olivier J.-L., Leininger-Muller B., Kriem B., Oster T., and Pillot T. N-truncated amyloid-β oligomers induce learning impairment and neuronal apoptosis. Neurobiol. Aging 29 (2007) 1319-1333
53. Zhang C., Lambert M.P., Bunch C., Barber K., Wade W.S., Krafft G.A., and Klein W.L. Focal adhesion kinase expressed by nerve cell line shows increased tyrosine phosphorylation in response to Alzheimer's A beta peptide. J. Biol. Chem. 269 (1994) 25247-25250